[Abstract Only] Randomized Trial: Clopidogrel Seems to Be a Better Choice for Patients > 70 years with Non-ST-elevation Acute Coronary Syndrome 26 Apr, 2020 | 21:14h | UTC Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial – The Lancet